B-FREE Chronic Babesiosis Study

A Phase 1, Single-Ascending-Dose Study of BT051 in Healthy Subjects

NCT05103878 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Effects of Dissolution Profile on the Pharmacokinetics of Single Oral Doses of Tafenoquine Tablets and Tafenoquine Stable Isotope Labelled Solution

NCT02751294 ·Status: COMPLETED ·Phase: PHASE1

Sun Protection Factor Assay (318/2016)

NCT02995031 ·Status: TERMINATED ·Phase: NA

A Study in Healthy Men to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body With or Without Food

NCT05337592 ·Status: COMPLETED ·Phase: PHASE1

A Pharmacokinetic Study to Evaluate BBI-5000 Capsules and Food Effect in Healthy Adult Subjects

NCT02590289 ·Status: COMPLETED ·Phase: PHASE1

BIIB014 Cardiovascular Monitoring Study

NCT01035515 ·Status: COMPLETED ·Phase: PHASE1

A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of BIIB091, a Bruton's Tyrosine Kinase (BTK) Inhibitor, in Healthy Adult Participants

NCT03943056 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions

NCT01532570 ·Status: COMPLETED ·Phase: PHASE3

Sun Protection Factor Assay (338/2016)

NCT02995109 ·Status: COMPLETED ·Phase: NA

A Study to Test How Food Influences the Amount of BI 1291583 in the Blood of Healthy Men

NCT03837964 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability and Pharmacokinetics of Multiple Rising Oral Doses of BI 44370 TA Tablets in Healthy Male and Female Volunteers

NCT02215759 ·Status: COMPLETED ·Phase: PHASE1

Study Will Evaluate the Relative Bioavailability, Safety, and Tolerability of Single Doses of Nifurtimox 30 mg Tablets Exhibiting Different in Vitro Dissolution Characteristics, and to Evaluate the Relative Bioavailability of Nifurtimox 30 mg and 120 mg

NCT03350295 ·Status: COMPLETED ·Phase: PHASE1

A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated and How Food Influences the Amount of BI 1569912 in the Blood

NCT04445090 ·Status: TERMINATED ·Phase: PHASE1

This Study Tests How Different Doses of BI 1291583 Are Taken up in the Body and How Well They Are Tolerated

NCT03414008 ·Status: TERMINATED ·Phase: PHASE1

A Study in Healthy Men to Test How BI 1839100 is Taken up and Handled by the Body

NCT06572111 ·Status: TERMINATED ·Phase: PHASE1

Excretion Balance of 14c-radiolabeled BIRB 796 BS in Normal Male Subjects

NCT02211885 ·Status: COMPLETED ·Phase: PHASE1

A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 425809 in the Blood

NCT03082183 ·Status: COMPLETED ·Phase: PHASE1

Sun Protection Factor Assay (317/2016)

NCT02995018 ·Status: COMPLETED ·Phase: NA

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 1356 BS in Healthy Male Volunteers

NCT02183298 ·Status: COMPLETED ·Phase: PHASE1

Safety of Single Rising Doses and Relative Bioavailability of BI 691751

NCT01843972 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising Oral Doses and Multiple Rising Oral Doses of BI 1356 BS in Healthy Male Volunteers

NCT02183311 ·Status: COMPLETED ·Phase: PHASE1

A Study to Learn How Different Forms of Study Medicine Tafamidis Are Taken Up Into The Blood in Healthy Adults

NCT06273839 ·Status: COMPLETED ·Phase: PHASE1

A Study To Estimate How Much Tafamidis Created In Different Ways Can Be Measured in Blood Samples

NCT02189330 ·Status: COMPLETED ·Phase: PHASE1

Sun Protection Factor Assay (339/2016)

NCT02995122 ·Status: COMPLETED ·Phase: NA

Drug-drug Interaction Trial Between Rifampicin and BI 409306 in Healthy Volunteers

NCT03151499 ·Status: COMPLETED ·Phase: PHASE1